By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins today said that it has signed on investment firm Bloom Burton as an advisor to the company.

Bloom Burton, based in Toronto, will provide strategic and financial services, including an overview and analysis of potential opportunities, financial modeling, analysis of Miraculins' business plan, an overview and assessment of financing options, and strategic partnership opportunities, Miraculins said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.